Which new forms of academia-industry partnerships to better mature assets?
Current roles: Managing Partner at Agbiopro (www.agbiopro.com) – The professional home for entrepreneurs and young startups providing outsourced Interim CEO, Intellectual Property, Business Development, fund rising, and R&D management. Mr. Levy is also the CEO and co-founder of APOrx – a seed-stage startup focusing on protein degradation drug discovery, and a lecturer teaching IP, Licensing and BD in the Faculty of Agriculture at the Hebrew University of Jerusalem.
Previous roles include CEO of the Galilee Research Institute – a 300+ employees translational research organization, CEO of Proteologics ltd who among its shareholders where GSK and Teva (Now Cannomed Medical Cannabis, TASE “CNMD-M”) and co-facilitator and Director at Immpact Bio, a company developing a novel strategy for improving current CAR-T therapies for solid tumors who among its shareholders are J&J and Takeda.
Mr. Levy’s Professional record includes leading of numerous licensing and collaboration deals, filing numerous patent applications, founding of several startups and leading a successful IPO.
Mr. Levy academic record include an Executive LL.M from Northwestern school of law, Chicago IL, an M.Sc. (Molecular biology) and LL.B degrees from Tel Aviv University and a BSc, Agr. from the Hebrew University of Jerusalem. Mr. Levy is a member of the Israeli bar specializing in IP, Licensing, tech deals and commercial law.